Rigel Pharmaceuticals Inc. (New) (RIGL) Net Income by Year
Rigel Pharmaceuticals Inc. (New) reported $367.0M in net income in fiscal year 2025. This represents an increase of 1999.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $321.9M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Rigel Pharmaceuticals Inc. (New) has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RIGL Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $321.9M | $367.0M+1999.1% | $17.5M+169.7% | -$25.1M+57.2% | -$58.6M-227.0% | -$17.9M+39.8% | -$29.7M+55.5% | -$66.9M+5.1% | -$70.5M+9.6% | -$78.0M-12.7% | -$69.2M-34.5% | -$51.5M+43.4% | -$90.9M-2.1% | -$89.0M+9.9% | -$98.8M-15.0% | -$86.0M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
RIGL Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Rigel Pharmaceuticals Inc. (New) financials
Frequently Asked Questions
What was Rigel Pharmaceuticals Inc. (New)'s net income in fiscal year 2025?
Rigel Pharmaceuticals Inc. (New) reported $367.0M in net income in fiscal year 2025.
How fast is Rigel Pharmaceuticals Inc. (New)'s net income growing?
Rigel Pharmaceuticals Inc. (New) (RIGL) net income rose by 1999.1% year over year, from $17.5M to $367.0M in fiscal year 2025.
What is Rigel Pharmaceuticals Inc. (New)'s net income over the last twelve months?
Rigel Pharmaceuticals Inc. (New) (RIGL) reported $321.9M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Rigel Pharmaceuticals Inc. (New)'s net income changed over the years?
Across the 15 fiscal years this page covers, Rigel Pharmaceuticals Inc. (New) (RIGL) net income went from -$86.0M in fiscal year 2011 to $367.0M in fiscal year 2025.
What was Rigel Pharmaceuticals Inc. (New)'s net income in the most recent quarter?
Rigel Pharmaceuticals Inc. (New) (RIGL) reported $17.3M in net income in Q2 2026. This represents a decrease of 71.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Rigel Pharmaceuticals Inc. (New) (RIGL) reported on that line in every period on record.